StreetInsider.com News Articles

Form SCHEDULE 13G Arcadia Biosciences, Filed by: ARMISTICE CAPITAL, LLC

Fri, 15 May 2026 11:29:00 -0400

si-local-file:///var/storage/secattach/20260515/26502205.html

Form SCHEDULE 13G Arcadia Biosciences, Filed by: ARMISTICE CAPITAL, LLC

Fri, 15 May 2026 11:29:00 -0400

si-local-file:///var/storage/secattach/20260515/26502205.html

Form 10-Q Arcadia Biosciences, For: Mar 31

Thu, 14 May 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260514/26494810.html

Form 10-Q Arcadia Biosciences, For: Mar 31

Thu, 14 May 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260514/26494810.html

Form 8-K Arcadia Biosciences, For: May 14

Thu, 14 May 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260514/26494723.html

Form 8-K Arcadia Biosciences, For: May 14

Thu, 14 May 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260514/26494723.html

Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights

Thu, 14 May 2026 16:05:00 -0400

-- Zola^® volumes increase 18% year-over-year --

-- SG&A at lowest level in Arcadia’s history --

DALLAS, May 14, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.^® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today released its financial and business results for the first quarter of 2026.

“We are very pleased with our performance during the first quarter of 2026,” said T.J. Schaefer, CEO of Arcadia. “We were able to bring in gross proceeds of approximately $2.1 million from the exercise of previously outstanding preferred investment options, Zola^®

Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights

Thu, 14 May 2026 16:05:00 -0400

-- Zola^® volumes increase 18% year-over-year --

-- SG&A at lowest level in Arcadia’s history --

Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights

Thu, 14 May 2026 16:05:00 -0400

-- Zola^® volumes increase 18% year-over-year --

-- SG&A at lowest level in Arcadia’s history --

Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights

Thu, 14 May 2026 16:05:00 -0400

-- Zola^® volumes increase 18% year-over-year --

-- SG&A at lowest level in Arcadia’s history --

Form 10-K/A Arcadia Biosciences, For: Dec 31

Thu, 30 Apr 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260430/26408278.html

Form 10-K/A Arcadia Biosciences, For: Dec 31

Thu, 30 Apr 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260430/26408278.html

Form 8-K Arcadia Biosciences, For: Mar 30

Fri, 03 Apr 2026 15:31:00 -0400

si-local-file:///var/storage/secattach/20260403/26271525.html

Form 8-K Arcadia Biosciences, For: Mar 30

Fri, 03 Apr 2026 15:31:00 -0400

si-local-file:///var/storage/secattach/20260403/26271525.html

Arcadia Biosciences (RKDA) Misses Q4 EPS by 97c

Thu, 26 Mar 2026 17:26:00 -0400

Arcadia Biosciences (NASDAQ: RKDA) reported Q4 EPS of ($0.97). Revenue for the quarter came in at $900 thousand.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

Form 10-K Arcadia Biosciences, For: Dec 31

Thu, 26 Mar 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260326/26224557.html

Form 10-K Arcadia Biosciences, For: Dec 31

Thu, 26 Mar 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260326/26224557.html

Form 8-K Arcadia Biosciences, For: Mar 26

Thu, 26 Mar 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260326/26224440.html

Form 8-K Arcadia Biosciences, For: Mar 26

Thu, 26 Mar 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260326/26224440.html

Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights

Thu, 26 Mar 2026 16:05:00 -0400

-- Zola^® revenues increase 17% year-over-year --

-- Arcadia and Roosevelt Resources terminate proposed business combination --

-- Exercise of preferred investment options yields $2.1 million gross proceeds --

DALLAS, March 26, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.^® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today released its financial and business results for the fourth quarter and full year of 2025.

“At the end of 2025, we received a termination notice from Roosevelt Resources related to the Securities Exchange Agreement concerning a proposed business combination,

Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights

Thu, 26 Mar 2026 16:05:00 -0400

-- Zola^® revenues increase 17% year-over-year --

-- Arcadia and Roosevelt Resources terminate proposed business combination --

-- Exercise of preferred investment options yields $2.1 million gross proceeds --

“At the end of 2025, we received a termination notice from Roosevelt Resources related to the Securities Exchange Agreement concerning a proposed business combination,

Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights

Thu, 26 Mar 2026 16:05:00 -0400

-- Zola^® revenues increase 17% year-over-year --

-- Arcadia and Roosevelt Resources terminate proposed business combination --

-- Exercise of preferred investment options yields $2.1 million gross proceeds --

“At the end of 2025, we received a termination notice from Roosevelt Resources related to the Securities Exchange Agreement concerning a proposed business combination,

Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights

Thu, 26 Mar 2026 16:05:00 -0400

-- Zola^® revenues increase 17% year-over-year --

-- Arcadia and Roosevelt Resources terminate proposed business combination --

-- Exercise of preferred investment options yields $2.1 million gross proceeds --

“At the end of 2025, we received a termination notice from Roosevelt Resources related to the Securities Exchange Agreement concerning a proposed business combination,

Form EFFECT Arcadia Biosciences,

Wed, 11 Feb 2026 06:05:00 -0400

si-local-file:///var/storage/secattach/20260211/25978712.html

Form EFFECT Arcadia Biosciences,

Wed, 11 Feb 2026 06:05:00 -0400

si-local-file:///var/storage/secattach/20260211/25978712.html